Carbon monoxide and nitric oxide mediate cytoskeletal reorganization in microvascular cells via vasodilator-stimulated phosphoprotein phosphorylation: Evidence for blunted responsiveness in diabetes

Diabetes

Volumn 57, Issue 9, 2008, Pages 2488-2494

  Calzi, Sergio Li ^a   Purich, Daniel L ^a   Chang, Kyung Hee ^a   Afzal, Aqeela ^a   Nakagawa, Takahiko ^b   Busik, Julia V ^c   Agarwal, Anupam ^b   Segal, Mark S ^a   Grant, Maria B ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b University of Alabama at Birmingham   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; CARBON MONOXIDE; NITRIC OXIDE; STROMAL CELL DERIVED FACTOR 1; VASOACTIVE AGENT; VASODILATOR STIMULATED PHOSPHOPROTEIN; ACTIN BINDING PROTEIN; CELL ADHESION MOLECULE; PHOSPHOPROTEIN; VASODILATOR-STIMULATED PHOSPHOPROTEIN;

ARTICLE; CD34 SELECTION; CELL MIGRATION; CELL STRUCTURE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOSKELETON; DIABETES MELLITUS; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MICROVASCULARIZATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; STEM CELL; THROMBOCYTE AGGREGATION; TISSUE PERFUSION; TREATMENT RESPONSE; VASODILATATION; CELL CULTURE; CELL MOTION; CYTOLOGY; DIABETIC ANGIOPATHY; DRUG EFFECT; FLOW CYTOMETRY; METABOLISM; MICROCIRCULATION; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; THROMBOCYTE;

BLOOD PLATELETS; CARBON MONOXIDE; CELL ADHESION MOLECULES; CELL MOVEMENT; CELLS, CULTURED; CYTOSKELETON; DIABETIC ANGIOPATHIES; ENDOTHELIAL CELLS; FLOW CYTOMETRY; HUMANS; MICROCIRCULATION; MICROFILAMENT PROTEINS; NITRIC OXIDE; PHOSPHOPROTEINS; PHOSPHORYLATION;

EID: 52749092933     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db08-0381     Document Type: Article

References (38)

1. Sikorski EM, Hock T, Hill-Kapturczak N, Agarwal A: The story so far: molecular regulation of the heme oxygenase-1 gene in renal injury. Am, J Physiol Renal Physiol 286:F425-F441, 2004
2. Abraham NG, Kappas A: Pharmacological and clinical aspects of heme oxygenase. Pharmacol Rev 60:79-127, 2008
3. Ryter SW, Choi AM: Heme oxygenase-1: molecular mechanisms of gene expression in oxygen-related stress. Antioxid Redox Signal 4:625-632, 2002
4. Wink DA, Feelisch M, Fukuto J, Chistodoulou D, Jourd'heuil D, Grisham MB, Vodovotz Y, Cook JA, Krishna M, DeGraff WG, Kim S, Gamson J, Mitchell JB: The cytotoxicity of nitroxyl: possible implications for the pathophysiological role of NO. Arch Biochem Biophys 351:66-74, 1998
5. Maines MD: The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol 37:517-554, 1997
6. Furchgott RF, Jothianandan D: Endothelium-dependent and -independent vasodilation involving cyclic GMP: relaxation induced by nitric oxide, carbon monoxide and light. Blood Vessels 28:52-61, 1991
7. Duckers HJ, Boehm M, True AL, Yet SF, San H, Park JL, Clinton Webb R, Lee ME, Nabel GJ, Nabel EG: Heme oxygenase-1 protects against vascular constriction and proliferation. Nat Med 7:693-698, 2001
8. Morita T, Mitsialis SA, Koike H, Liu Y, Kourembanas S: Carbon monoxide controls the proliferation of hypoxic vascular smooth muscle cells. J Biol Chem 272:32804-32809, 1997
9. Nolan S, Dixon R, Norman K, Hellewell P, Ridger V: Nitric oxide regulates neutrophil migration through microparticle formation. Am J Pathol 172: 265-273, 2008
10. Xiao Q, Kiechl S, Patel S, Oberhollenzer F, Weger S, Mayr A, Metzler B, Reindl M, Hu Y, Willeit J, Xu Q: Endothelial progenitor cells, cardiovascular risk factors, cytokine levels and atherosclerosis: results from a large population-based study. PLoS ONE 2: e975, 2007
11. Zhang M, Zhou SH, Li XP, Shen XQ, Fang ZF: A novel hypothesis of atherosclerosis: EPCs-mediated repair-to-injury. Med Hypotheses 70:838-841, 2008
12. Liew A, Barry F, O'Brien T: Endothelial progenitor cells: diagnostic and therapeutic considerations. Bioessays 28:261-270, 2006
13. Segal MS, Shah R, Afzal A, Perrault CM, Chang K, Schuler A, Beem E, Shaw LC, Li Calzi S, Harrison JK, Tran-Son-Tay R, Grant MB: Nitric oxide cytoskeletal-induced alterations reverse the endothelial progenitor cell migratory defect associated with diabetes. Diabetes 55:102-109, 2006
14. Dickinson RB, Purich DL: Clamped-filament elongation model for actin- based motors. Biophys J 82:605-617, 2002
15. Gomez TM, Robles E: The great escape; phosphorylation of Ena/VASP by PKA promotes filopodial formation. Neuron 42:1-3, 2004
16. Reinhard M, Jarchau T, Walter U: Actin-based motility: stop and go with Ena/VASP proteins. Trends Biochem Sci 26:243-249, 2001
17. Deshane J, Chen S, Caballero S, Grochot-Przeczek A, Was H, Li Calzi S, Lach R, Hock TD, Chen B, Hill-Kapturczak N, Siegal GP, Dulak J, Jozkowicz A, Grant MB, Agarwal A: Stromal cell-derived factor 1 promotes angiogenesis via a heme oxygenase 1-dependent mechanism. J Exp Med 204:605-618, 2007
18. Ramamurthi A, Lewis RS: Measurement and modeling of nitric oxide release rates for nitric oxide donors. Chem Res Toxicol 10:408-413, 1997
19. Alberto R, Motterlini R: Chemistry and biological activities of CO-releasing molecules (CORMs) and transition metal complexes. Dalton Trans 17: 1651-1660, 2007
20. Dickinson RB, Caro L, Purich DL: Force generation by cytoskeletal filament end-tracking proteins. Biophys J 87:2838-2854, 2004
21. Halbrugge M, Friedrich C, Eigenthaler M, Schanzenbacher P, Walter U: Stoichiometric and reversible phosphorylation of a 46-kDa protein in human platelets in response to cGMP- and cAMP-elevating vasodilators. J Biol Chem 265:3088-3093, 1990
22. Jarchau T, Mund T, Reinhard M, Walter U: Purification and assays of vasodilator-stimulated phosphoprotein. Methods Enzymol 298:103-113, 1998
23. Rottner K, Behrendt B, Small JV, Wehland J: VASP dynamics during lamellipodia protrusion. Nat Cell Biol 1:321-322, 1999
24. Schatteman GC, Hanlon HD, Jiao C, Dodds SG, Christy BA: Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice. J Clin Invest 106:571-578, 2000
25. Schatteman GC, Awad O: Hemangioblasts, angioblasts, and adult endothelial cell progenitors. Anat Rec A Discov Mol Cell Evol Biol 276:13-21, 2004
26. Tokuo H, Ikebe M: Myosin X transport Mena/VASP to the tip of filopodia. Biochem Biophys Res Commun 319:214-220, 2004
27. Purich DL, Southwick FS: ABM-1 and ABM-2 homology sequences: consensus docking sites for actin-based motility defined by oligoproline regions in Listeria ActA surface protein and human VASP. Biochem Biophys Res Commun 231:686-691, 1997
28. Zhang Y, Tu Y, Gkretsi V, Wu C: Migfilin interacts with vasodilator- stimulated phosphoprotein (VASP) and regulates VASP localization to cell-matrix adhesions and migration. J Biol Chem 281:12397-12407, 2006
29. Benz PM, Blume C, Moebius J, Oschatz C, Schuh K, Sickmann A, Walter U, Feller SM, Renne T: Cytoskeleton assembly at endothelial cell-cell contacts is regulated by alphaII-spectrin-VASP complexes. J Cell Biol 180:205-219, 2008
30. Walter U, Geiger J, Haffner C, Markert T, Nehls C, Silber RE, Schanzen-bacher P: Platelet-vessel wall interactions, focal adhesions, and the mechanism of action of endothelial factors. Agents Actions Suppl 45:255-268, 1995
31. Smolenski A, Bachmann C, Reinhard K, Honig-Liedl P, Jarchau T, Hoschuetzky H, Walter U: Analysis and regulation of vasodilator-stimulated phosphoprotein serine 239 phosphorylation in vitro and in intact cells using a phosphospecific monoclonal antibody. J Biol Chem 273:20029-20035, 1998
32. Coburn RF, Williams WJ, Forster RE: Effect of erythrocyte destruction on carbon monoxide production in man. J Clin Invest 43:1098-1103, 1964
33. Nathanson JA, Scavone C, Scanlon C, McKee M: The cellular Na+ pump as a site of action for carbon monoxide and glutamate: a mechanism for long-term modulation of cellular activity. Neuron 14:781-794, 1995
34. Maines MD, Trakshel GM: Differential regulation of heme oxygenase isozymes by Sn and Zn-protoporphyrins: possible relevance to suppression of hyperbilirubinemia. Biochim Biophys Acta 1131:166-174, 1992
35. Maines MD: Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications. FASEB J 2:2557-2568, 1988
36. Dulak J, Deshane J, Jozkowicz A, Agarwal A: Heme oxygenase-1 and carbon monoxide in vascular pathobiology: focus on angiogenesis. Circulation 117:231-241, 2008
37. Nowell SA, Leakey JE, Warren JF, Lang NP, Frame LT: Identification of enzymes responsible for the metabolism of heme in human platelets. J Biol Chem 273:33342-33346, 1998
38. Kourembanas S: Hypoxia and carbon monoxide in the vasculature. Antioxid Redox Signal 4:291-299, 2002